Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
The Real Rate Index45.30.00Palanor: Inflation Pulse50.7+0.09Palanor: Geopolitical Stress60.0-2.16Palanor: Liquidity57.9-0.79Palanor: Capital Tightness47.5+0.91Palanor: Industrial Pulse70.10.00Palanor: AI Margin Compression53.4+0.29Palanor: Consumer Confidence48.6+0.50Palanor: US Dollar Strength46.50.00Palanor: Labor Heat63.2-0.01Palanor: Recession Vocabulary28.1+0.54Palanor: Uncertainty Index53.4+1.24Palanor: US Jobs Health40.30.00Palanor: Energy Transition37.0-0.52Palanor: Reshoring Sentiment22.8+0.54Palanor: AI Substitution28.4-0.24The Social Fabric Index45.70.00Palanor: Geopolitical Anxiety19.4-0.45Palanor: Quit Pressure37.6+0.42The Mania Index88.00.00The Palanor Index57.1-0.51Cost Disease Spread33.20.00Palanor: US vs China49.5-0.17Rise of Socialism Index40.8-0.26The Bubble Memory79.90.00Palanor: Steward Confidence50.8+0.13The Long Watch90.30.00The Reshoring Index55.2+0.00The Capital Return Index81.0-0.75The Discourse Index72.4+1.83The Hesitation Index30.8-6.58Palanor AI Inference Cost Index71.2-0.03The AI Capex Race Index78.4+1.36The Boardroom Index82.5-0.00The Layoff Cycle Index32.8-2.51Capital Deployment Posture Index62.3+1.26The Consumer Health Index41.7-2.96Labor Hours Composite44.40.00The Dollar Erosion Index66.6+0.14Palanor: Risk Appetite36.2+0.83
PalanorPalanor

Line/From the Studio

FDA Novel Drug Approvals, Trailing 12 Months

New molecular entities and new therapeutic biologics approved by FDA's Center for Drug Evaluation and Research.

59.0 in Sep 2026the highest since 2023+24.0 since Sep 2016
YTD1y2y5y10y20yAll
Forecast availableOffContinuationForesight™
Show · 1 ▾
U.S. recessionsShades the months the NBER dates as recession. U.S. charts only.5-year rangeThe highest and lowest readings of the last five years, as a band. One-series charts only.High and lowMarks the highest and lowest readings in the window shown.
Current·Data to Sep 2026

Plays the chart through its history. Pauses are where the data set a record or moved most.

What this chart reads

Sources

FDA Novel Drug Approvals (Trailing 12 Months). Source: U.S. Food and Drug Administration: "Compilation of CDER NME and New Biologic Approvals 1985–2025" and the "Novel Drug Approvals" page for each later year. FDA website content is in the public domain.

Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.

Related charts

HealthForecast

FDA Novel Drug Approvals

New drugs approved by the FDA’s drug center, trailing 12 months

59Data 51 days ago
HealthForecast

Drug Stocks Against the Market

Twenty large U.S.-listed drugmakers (by market value) and the S&P 500, price indexed to the start of the window

197.2Data yesterday
HealthForecast

U.S. Uninsured Rate

Share of people in the United States with no health insurance, annual, %

8.2%Data to Dec 2024
HealthForecast

U.S. Drug Overdose Deaths

Drug overdose deaths in the U.S., 12 months ending each month

66,478Data to May 2026
HealthForecast

Donor Aid for Health

Bilateral aid disbursements from DAC member countries by sector, US$ billions, current prices, yearly

$7.3B1 viewsData to Dec 2024
HealthForecast

Crop Yields and Farmland

U.S. corn and wheat yields and the share of land used for farming, indexed to 1961 = 100

290Data today

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.